Ray Dalio Novo Cure LTD Transaction History

Bridgewater Associates, LP

$21.1 Billion
Q4 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Novo Cure LTD stock. As of the latest transaction made, Bridgewater Associates, LP holds 11,119 shares of NVCR stock, worth $216,709. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,119

Previous 39,383 71.77%

Holding current value

$216,709

Previous $615,000 46.18%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$14.54 - $33.41 $410,958 - $944,300	-28,264 Reduced 71.77%	11,119 $331,000
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $654,027 - $977,899	-41,898 Reduced 51.55%	39,383 $615,000
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $191,421 - $389,153	-16,181 Reduced 16.6%	81,281 $1.39 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $140,172 - $195,134	11,286 Added 13.1%	97,462 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $657,204 - $931,777	59,048 Added 217.66%	86,176 $1.29 Million
Q3 2023 Nov 13, 2023	SELL	$16.15 - $42.35 $1.42 Million - $3.73 Million	-88,098 Reduced 76.46%	27,128 $438,000
Q2 2023 Aug 11, 2023	SELL	$40.29 - $82.51 $504,350 - $1.03 Million	-12,518 Reduced 9.8%	115,226 $4.78 Million
Q1 2023 May 12, 2023	SELL	$56.44 - $118.81 $451,463 - $950,361	-7,999 Reduced 5.89%	127,744 $7.68 Million
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $1.97 Million - $2.63 Million	-30,759 Reduced 18.47%	135,743 $9.96 Million
Q3 2022 Nov 10, 2022	BUY	$67.99 - $89.57 $1.02 Million - $1.35 Million	15,032 Added 9.92%	166,502 $12.7 Million
Q2 2022 Aug 11, 2022	BUY	$56.6 - $89.9 $859,754 - $1.37 Million	15,190 Added 11.15%	151,470 $10.5 Million
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $2.22 Million - $3.12 Million	36,879 Added 37.1%	136,280 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $247,388 - $401,957	3,295 Added 3.43%	99,401 $7.46 Million
Q3 2021 Nov 12, 2021	SELL	$116.17 - $194.55 $62,267 - $104,278	-536 Reduced 0.55%	96,106 $11.2 Million
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $12.6 Million - $21.8 Million	96,642 New	96,642 $21.4 Million

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

75.6M

Call Options Held

1.77M

Put Options Held

538K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.05B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account